Denosumab Subcutaneous and NovoLog PenFill
Determining the interaction of Denosumab Subcutaneous and NovoLog PenFill and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: denosumab
Brand name: Prolia, Xgeva
Synonyms: Denosumab
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Denosumab Subcutaneous-Novoseven
- Denosumab Subcutaneous-NovoSeven RT
- Denosumab Subcutaneous-NovoSeven RT with MixPro injection
- Denosumab Subcutaneous-Novothyrox
- Denosumab Subcutaneous-Noxafil
- Denosumab Subcutaneous-Noxafil (Posaconazole Delayed-Release Tablets)
- NovoLog PenFill-Denovo
- NovoLog PenFill-Dent-O-Kain/20
- NovoLog PenFill-Denti-Care Denti-Freeze Topical Anesthetic
- NovoLog PenFill-DentiPatch
- NovoLog PenFill-Deoxycholic acid
- NovoLog PenFill-Deoxycholic acid Subcutaneous